New drug trial hopes to slow kidney damage in rare alport syndrome
Disease control
Not yet recruiting
This study tests a drug called exaluren in 24 people aged 12 and older with Alport syndrome caused by specific genetic mistakes. The drug aims to improve kidney structure and reduce protein in urine. Participants first receive either exaluren or a placebo for 16 weeks, then every…
Phase: PHASE2 • Sponsor: Eloxx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 17:23 UTC